Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name BMF-219
Trade Name
Synonyms BMF219|BMF 219
Drug Descriptions

BMF-219, is an irreversible menin inhibitor, which potentially decreases expression of KRAS, MYC, and BCL2, and reduces tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2665; Blood (2021) 138 (Supplement 1): 4318.).

CAS Registry Number NA
NCIT ID C185864


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BMF-219 BMF-219 1 2
BMF-219 + Venetoclax BMF-219 Venetoclax 0 0

Additional content available in CKB BOOST